Klingenstein Fields & Co Lp
Source: SEC Form 13F · as of Mar 2026Klingenstein Fields & Co Lp holds 19 biotech & pharma companies tracked by BioSniper, totaling $206.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
19
Total value held
$206.6M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 102,848 | $94.6M |
| JNJJOHNSON & JOHNSON | 221,534 | $54.2M |
| MRKMerck & Co., Inc. | 224,870 | $27.0M |
| REGNREGENERON PHARMACEUTICALS, INC. | 15,566 | $12.0M |
| ABTABBOTT LABORATORIES | 110,302 | $11.3M |
| PMPhilip Morris International Inc | 9,459 | $1.6M |
| ABBVAbbVie Inc. | 5,537 | $1.2M |
| GILDGILEAD SCIENCES, INC. | 7,919 | $1.1M |
| BIIBBIOGEN INC. | 2,731 | $501K |
| NVSNovartis AG | 3,047 | $465K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,005 | $449K |
| AMGNAMGEN INC | 1,142 | $402K |
| NVONovo Nordisk A/S | 9,820 | $361K |
| GMOptec International, Inc. | 4,158 | $310K |
| PFEPFIZER INC | 9,547 | $268K |
| IQVIQVIA Holdings Inc. | 1,321 | $225K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,731 | $206K |
| BMYBRISTOL MYERS SQUIBB CO | 3,366 | $204K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 748 | $202K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.